NEWS
Sophim set to double production capacity
French natural cosmetic ingredient maker Sophim has completed a €20m ($21.43m) funding round to double its production capacity and accelerate international sales. Existing investor Smalt Capital
has injected a further €4.5m that will be used to boost output from Sophim’s facilities in Peyruis, France and Almeria, Spain. One of the Alpes de Haute
Provence company’s flagship products is Phytosqualan, is a squalane that is 100% of vegetable origin, made from olives. Developed in the company’s
R&D laboratory, the production of squalane follows the principles of the circular economy, by recovering olive fatty acids. “In our rapidly growing
environment, sustainable development must remain a priority,” said Sophim managing director Alexis Margnat. “Ecological responsibility is at our heart and has always been an essential element in the development of our business project.” Marseille-based Smalt Capital
has been investing in Sophim – which was founded in 1996 - since 2014.
“We are proud to continue the
adventure with Sophim,” said Julien Jorge, manager at Smalt Capital. “Beyond purely financial
criteria, the human, collective and ecological dimension occupies a central place in Sophim’s corporate culture. We are confident in the company’s ability to build on its competitive advantages to establish itself as a leader in its field,” he added. Sophim president Jacques
Margnat said: “This investment will allow us to double our production capacity at our two industrial sites, to meet strong demand for our products, especially internationally.”
Brenntag to acquire Chemgrit
Brenntag has struck a deal to acquire Chemgrit, a speciality chemical distributor headquartered in Johannesburg, South Africa. The acquisition, financial
details of which were not disclosed, is expected to be completed during the fourth quarter of 2023. Brenntag will integrate
Chemgrit’s personal care operations into its Personal Care & HI&I business unit. The German firm said the
combined businesses will accelerate growth in cosmetics
and extend the application and technical support services also to HI&I cleaning customers. The enlarged Brenntag
Specialties business in South Africa will be scaled to other African markets, adding to Brenntag’s current African presence with local entities in Maghreb, Ghana, Nigeria, East Africa, Mauritius and South Africa. “With this acquisition, we
execute Brenntag’s ‘Strategy to Win’ and enrich the capabilities, scope and scale for Brenntag Specialties in Southern Africa,” said Michael Friede, CEO Brenntag Specialties.
“Chemgrit’s cosmetics
focus perfectly complements our existing national food and pharma business in Life Science and supports our ambition to achieve an ever-stronger position with a comprehensive offering in South Africa and beyond,” he added.
9
Chinese buy Korean pigment
maker CQV Chinese outfit Global New Material International Holdings has acquired Korean cosmetic pigment manufacturer CQV. Hong Kong-listed Global New
Material International Holdings now holds 42.45% of CQV, which has become a non-wholly owned subsidiary. Global New Material
International Holdings says CQV is renowned for its advanced expertise in producing mica- based products and cutting- edge pearlescent materials for the industrial, automotive and cosmetic sectors. CQV operates an extensive
sales and distribution network covering more than 100 countries and regions globally with a wide customer base of international companies. Global New Material
International specializes in the manufacturing and sale of pearlescent pigment products and artificial synthetic mica. The financial terms of the deal
were not disclosed. “The directors believe that the
acquisition offers a good chance for the group to tap opportunities in and expand its business presence in the international pearlescent pigments industry,” said a Global New Material International statement. “Through the acquisition
and control of CQV, the group can leverage on the experience, knowhow and market presence of CQV, increase its market share, enhance its product offerings and thereby increase the overall competitiveness of the group,” it added.
Grant Industries’ BCR partners with Aethera Biotech
Grant Industries business BCR BioComponent Research has expanded its product offering by entering into a partnership with Aethera Biotech to bring COSMOS- approved actives to the US and Canada personal care markets. Aethera Biotech is an Italian
company that focuses on plant- based solutions to drive innovation in cosmetics and nutraceuticals. The Vicenza firm’s CROP
biotechnological platform provides
www.personalcaremagazine.com
a non-GMO and alternative option to conventional farming methods, being able to produce potentially infinite quantities of actives through
the power of plant cells. The platform enables the
creation of safe and consistently high-quality phytocomplexes for use in various personal care applications. These products are made from
plant-based materials and are guaranteed to meet high standards of quality, effectiveness, and safety. “The Aethera team is thrilled
to start this new and important collaboration with such an excellent partner as BCR, longing to spread
innovation in the American cosmetic sector through our biotech plant cell ingredients,” said Aethera Biotech chief executive Daniele Baghi. We are certain that Aethera’s cutting-edge materials will blend seamlessly with our existing portfolio. Our business ethos is centred around ‘Science Meets Nature,’ so partnering with Aethera was a natural choice, given their focus on creating potent plant-based actives”, said Grant marketing manager Naomi Bedford.
October 2023 PERSONAL CARE
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108
